KLK3 and benign prostatic hyperplasia: With this technique, the PSA and autoantibody levels in 99 CaP and benign prostatic hypertrophy (BPH) patient serum samples were analyzed, and we found that this panel is capable of differentiating CaP from BPH with an ROC AUC of 0.916.